Fundz

Marker Therapeutics reported raising $16.1 Million in an initial SEC Form D filing, from an offering of $16.1 Million

PUBLIC · MRKRDec 30, 2024

Amount Raised

$16.1 Million

$16.1 Million sold, per SEC Form D (first sale Dec 23, 2024)

Round Type

Venture

HoustonBiotechnology

Investors

Aisling CapitalNew Enterprise AssociatesBlue Owl Healthcare Opportunities

Quick answer

Marker Therapeutics raised $16.1 Million in a funding round, dated December 23, 2024. Investors: Aisling Capital, New Enterprise Associates and Blue Owl Healthcare Opportunities. Marker Therapeutics is based in Houston, Texas, United States.

How much did Marker Therapeutics raise?
Marker Therapeutics raised $16.1 Million in a funding round on December 23, 2024.
Who invested in Marker Therapeutics?
Aisling Capital, New Enterprise Associates and Blue Owl Healthcare Opportunities are named as investors in this round.
What does Marker Therapeutics do?
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
Where is Marker Therapeutics based and how big is it?
Marker Therapeutics is based in Houston, Texas, United States. Fundz records about 29 employees.
Who are the decision-makers at Marker Therapeutics?
Fundz holds 2 contacts at Marker Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Marker Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Kytopen raised $7.1M on February 6, 2025.
  • KOA Biotech raised $2.1M (Seed) on February 6, 2025.
  • Astral Systems raised $5.6M (Angel) on February 6, 2025.
  • Entos Pharmaceuticals raised $4M (Seed) on February 5, 2025.
  • Modern Synthesis raised $5.5M (Funding Round) on February 5, 2025.
  • Miist Therapeutics raised $7M (Seed) on February 5, 2025.

Who to call at Marker Therapeutics, and when

A new round usually means Marker Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Marker Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Marker Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Marker Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Marker Therapeutics

Location

2450 HOLCOMBE BLVD

Houston, Texas, United States

About

Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Marker Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts27 people are listed at Marker Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Marker Therapeutics's next move

See what Strategic adds

Marker Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.